angiotensin ii has been researched along with a 81988 in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 9 (90.00) | 18.2507 |
2000's | 1 (10.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anania, V; Demontis, MP; Fattaccio, MC; Glorioso, N; Madeddu, P; Palomba, D; Parpaglia, PP; Pollock, D; Varoni, MV | 1 |
Divish, BJ; Opgenorth, TJ; Polakowski, JS; Pollock, DM | 1 |
Adler, AL; Brune, ME; De, B; DeBernardis, JF; Kerkman, DJ; Lee, JY; Opgenorth, TJ; Warner, RB; Winn, M; Zydowsky, TM | 1 |
Brune, M; Buckner, SA; De, B; Hancock, AA; Lee, JY; Morse, PA; Oheim, K; Warner, RB; Winn, M; Zydowsky, TM | 1 |
DeBernardis, JF; Hancock, AA; Kerkman, DJ; Opgenorth, TJ; Rotert, G; Sorensen, BK; Surber, BW; Tasker, AS; Thomas, S; Vodenlich, AD | 1 |
Brune, ME; Buckner, SA; De, B; Debernardis, JF; Kerkman, DJ; Lee, JY; Opgenorth, TJ; Warner, RB; Winn, M; Zydowsky, TM | 1 |
Altenbach, RJ; Basha, FZ; Boyd, SA; Brune, ME; Buckner, SA; Crowell, D; De, B; Drizin, I; Winn, M; Zydowsky, TM | 1 |
Granger, JP; Solhaug, MJ; Wallace, MR | 1 |
Anania, V; Demontis, MP; Dessì-Fulgheri, P; Emanueli, C; Glorioso, N; Madeddu, P; Palomba, D; Sarzani, R; Varoni, MV | 1 |
Capogrossi, MC; Emanueli, C; Madeddu, P; Maestri, R; Minasi, A; Olivetti, G; Salis, MB | 1 |
10 other study(ies) available for angiotensin ii and a 81988
Article | Year |
---|---|
Prevention by blockade of angiotensin subtype1-receptors of the development of genetic hypertension but not its heritability.
Topics: Administration, Oral; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biomarkers; Blood Pressure; Body Weight; Disease Models, Animal; Diuresis; Female; Genetic Diseases, Inborn; Heart; Hypertension; Injections, Intravenous; Injections, Intraventricular; Male; Nicotinic Acids; Organ Size; Phenotype; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renin-Angiotensin System; Tetrazoles | 1995 |
Angiotensin blockade reverses hypertension during long-term nitric oxide synthase inhibition.
Topics: Amino Acid Oxidoreductases; Angiotensin II; Animals; Arginine; Diuresis; Dose-Response Relationship, Drug; Hypertension; Male; Nicotinic Acids; Nitric Oxide Synthase; Nitroarginine; Proteinuria; Pyridines; Rats; Rats, Sprague-Dawley; Renin; Tetrazoles; Time Factors | 1993 |
Cardiovascular effects of orally administered ABBOTT-81988, an angiotensin II antagonist, in conscious spontaneously hypertensive rats.
Topics: Administration, Oral; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Heart Rate; Hemodynamics; Hypertension; Male; Nicotinic Acids; Rats; Rats, Inbred SHR; Tetrazoles | 1994 |
Receptor interactions of Abbott-81988, a highly potent, non-peptide angiotensin-II antagonist selective for type-1 receptors.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Lethal Dose 50; Male; Mice; Nicotinic Acids; Rabbits; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Tetrazoles | 1994 |
[3H]A-81988, a potent, selective, competitive antagonist radioligand for angiotensin AT1 receptors.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Binding, Competitive; Cells, Cultured; Liver; Male; Nicotinic Acids; Radioligand Assay; Rats; Rats, Sprague-Dawley; Tetrazoles | 1994 |
Characterization of antihypertensive activity of ABBOTT-81988, a nonpeptide angiotensin II antagonist in the renal hypertensive rat.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Bradykinin; Electrocardiography; Hemodynamics; Hypertension, Renal; Male; Nicotinic Acids; Norepinephrine; Rats; Rats, Sprague-Dawley; Tetrazoles; Vasopressins | 1994 |
2-(Alkylamino)nicotinic acid and analogs. Potent angiotensin II antagonists.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Aorta; Biological Availability; Iodine Radioisotopes; Liver; Male; Muscle Contraction; Niacin; Nicotinic Acids; Rabbits; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Receptors, Angiotensin; Tetrazoles | 1993 |
Nitric oxide and angiotensin II regulation of renal hemodynamics in the developing piglet.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Hemodynamics; Kidney; NG-Nitroarginine Methyl Ester; Nicotinic Acids; Nitric Oxide; Regional Blood Flow; Renin; Swine; Tetrazoles; Vascular Resistance | 1996 |
Cardiovascular phenotype of a mouse strain with disruption of bradykinin B2-receptor gene.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Bradykinin Receptor Antagonists; Cardiovascular Physiological Phenomena; Diet, Sodium-Restricted; Enzyme Inhibitors; Kidney; Mice; Myocardium; NG-Nitroarginine Methyl Ester; Nicotinic Acids; Phenotype; Receptors, Angiotensin; Receptors, Bradykinin; Renin; RNA, Messenger; Species Specificity; Tetrazoles | 1997 |
Angiotensin II type 1 receptor blockade prevents cardiac remodeling in bradykinin B(2) receptor knockout mice.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Female; Fibrosis; Heart Failure; Heart Rate; Heart Ventricles; Hypertension; Hypertrophy, Left Ventricular; Male; Mice; Mice, Knockout; Myocardium; Nicotinic Acids; Organ Size; Phenotype; Pregnancy; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptor, Bradykinin B2; Receptors, Bradykinin; Tetrazoles | 2000 |